[Seite 104↓]

Literaturverzeichnis

1 Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol. 2001; 79(4): 376-84

2 Adcock IM. Molecular mechanisms of glucocorticoid actions. Pulm Pharmacol Ther. 2000; 13(3): 115-26

3 Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med. 1996; 154(3 Pt 1): 771-82

4 Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol. 1995; 268: C331-8

5 Almawi WY, Tamim H. Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells. Cell Transplant. 2001; 10(2): 161-4

6 Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995; 270(5234): 286-90

7 Bamberger CM, Chrousos GP. Glucocorticoid receptor and RU 486 in man. Ann N Y Acad Sci. 1995; 761: 296-310

8 Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid actions in humans. J Clin Invest. 1995; 95(6): 2435-41

9 Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998; 94(6): 557-72

10 Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, Bienert M, Radbruch A, Burmester GR, Lauster R, Scheffold A, Buttgereit F. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 2004; 18(1): 70-80

11 Beato M, Chavez S, Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996; 61(4): 240-51

12 Bennett MC, Mlady GW, Fleshner M, Rose GM. Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity. Proc Natl Acad Sci. 1996; 93(3): 1330-4

13 Berki T, Kumanovicz G, Kumanovicz A, Falus A, Ujhelyi E, Nemeth P. Production and flowcytometric application of a monoclonal anti-glucocorticoid receptor-antibody. J Immunol Methods. 1998; 214(1-2): 19-27


[Seite 105↓]

14 Bernauer S, Wehling M, Gerdes D, Falkenstein E. The human membrane progesterone receptor gene: genomic structure and promoter analysis.DNA Seq. 2001; 12(1): 13-25

15 Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell. 2002; 110(1): 93-105

16 Borski RJ, Hyde GN, Fruchtman S. Signal transduction mechanisms mediating rapid, nongenomic effects of cortisol on prolactin release. Steroids. 2002; 67(6): 539-48

17 Borski RJ. Nongenomic membrane actions of glucocorticoids in vertebrates. Trends Endocrinol Metab. 2000; 11(19): 427-36

18 Borski RJ, Helms LM, Richman NH, Grau EG. Cortisol rapidly reduces prolactin release and cAMP and Ca2+ accumulation in the cichlid fish pituitary in vitro. Proc Natl Acad Sci. 1991; 88(7): 2758-62

19 Borsook H, Jiggins S, Wilson RT. Two inducers of rapid erythroblast multiplication in vitro. Nature. 1971; 230: 328-30

20 Boumpas DT. A novel action of glucocorticoids--NF-kappa B inhibition.Br J Rheumatol. 1996; 35(8): 709-10

21 Bøyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood: General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest. Suppl. 1968; 97: 51-76

22 Bøyum A. Seperation of white blood cells. Nature. 1964; 204: 793-94

23 Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin TS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR. Methyprednisolone or naloxone treatment after acute spinal cord injury. 1-year follow-up data. J Neurosurg. 1992; 76: 2-31

24 Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutical use. Am J Clin Dermatol. 2002; 3(1): 47-58

25 Brown GC. Control of respiration and ATP-synthesis in mammalian mitochondria and cells. J Biochem. 1992; 284: 1-13

26 Brusaferri F, Candlise L. Steroids for multiple sclerosis and optic neuritis. A meta-analysis of randomized controlled clinical trials. J Neurol. 2000; 247(6): 435-42

27 Buck C, Bundschu J, Gallati H, Bartmann P, Pohlandt F. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics. 1994; 93(1): 54-8

28 Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immun cells. Steroids. 2002; 67: 529-34


[Seite 106↓]

29 Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Kohler L, van Riel P, Vischer T, Bijlsma JW. Standardised nomenclature of glucocorticoid dosages and glucocorticoid treatment regimes: current questions and tentative answers in rheumatology. Ann Rheum Diss. 2002 ; 61(8): 718-22

30 Buttgereit F, Burmester GR, Brand MD. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today. 2000; 21: 192-9

31 Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for nongenomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem pharmacol. 1999; 58: 363-8

32 Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions. Arthritis Rheum. 1998; 41(5): 761-7

33 Buttgereit F, Krauss S, Brand MD. Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into Con A stimulated thymocytes. J Biochem. 1997; 326: 329-32

34 Buttgereit F, Dimmeler S, Neugebauer E, Burmester GR. Wirkungsmechanismen der hochdosierten Glucocorticoidtherapie. Dtsch Med Wschr. 1996; 121: 248-52

35 Buttgereit F, Brand MD. A hierarchy of ATP-consuming processes in mammalian cells. J Biochem. 1995; 312: 163-7

36 Buttgereit F, Brink I, Thiele B, Burmester GR, Hiepe F, Hall ED. Effects of methylprednisolone and 21-aminosteroids on mitogen-induced interleukin-6 and tumor necrosis factor-alpha production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther. 1995; 275(2): 850-3

37 Buttgereit F, Grant A, Müller M, Brand MD. The effects of methylprednisolone on oxidative phosphorylation in Con A-stimulated thymocytes: top down elasticity analysis and control analysis. Eur J Biochem. 1994; 223: 513-19

38 Buttgereit F, Brand MD, Müller M. Effects of methylprednisolone on the energy metabolism of quiescent and Con A-stimulated thymocytes of the rat. Biosci Rep. 1993; 13: 41-52

39 Buttgereit F, Brand MD, Müller M. Con A induced changes in erergy metabolism of rat thymocytes. Biosci Rep. 1992; 12: 381-6

40 Buttgereit F, Müller M, Rapoport SM. Quantification of ATP-producing and consuming processes in quiescent pig spleen lymphocytes. Biochem Int. 1991; 42: 59-67

41 Cato AC, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signalling pathways. Sci STKE. 2002; 138: 9

42 Chen D, Kohli K, Zhang S, Danielsen M, Stallcup MR. Phenylalanine-780 near the C-terminus of the mouse glucocorticoid receptor is important for ligand binding affinity and specificity. Mol Endocrinol. 1994; 8: 422-30

43 Chen F, Watson CF, Gametchu B. Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor enriched S-49 mouse lymphome cells. J Cell Biochem. 1999; 74(3): 418-29


[Seite 107↓]

44 Chen F, Watson CF, Gametchu B. Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells. J Cell Biochem. 1999; 74(3): 430-46

45 Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases.Blood. 1999; 93(7): 2282-96

46 Clark LC. U.S. Patent No 2913 386. USA, 1959

47 Croxtall JD, van Hal PTW, Choudhury Q, Gilroy DW, Flower RJ. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol. 2002; 135(2): 511-9

48 Croxtall JD, Chudhury Q, Flowers RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor dependent, transcription independent mechanism. Br J Pharm. 2000; 130(2): 289-98

49 Da Silva JAP, Bijlsma JWJ. Optimizing glucocorticoid therapy in rheumatoid arthritis. Rheum Dis Clin N Am. 2000; 26: 859-80

50 Dahlberg E, Thalen A, Brattsand R, Gustafsson JA, Johansson U, Roempke K, Saartok T. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids. Mol Pharmacol. 1984; 25(1): 70-8

51 Dallaporta B, Marchetti P, de Pablo MA, Maisse C, Duc HT, Metivier D, Zamzami N, Geuskens M, Kroemer G. Plasma membrane potential in thymocyte apoptosis. J Immunol. 1999; 162(11): 6534-42

52 Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992; 13(8): 795-808

53 DeRijk RH, Schaaf M, de Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol. 2002; 81(2): 103-22

54 Diba F, Watson CS, Gametchu B. 5´UTR sequences of the glucocorticoid receptor encode a peptide associated with translational regulation of the glucocorticoid receptor. J Cell Biochem. 2001; 81(1): 149-61

55 Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002; 39: 531-6

56 Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Baehr M. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci. 2003; 23(18): 6993-7000

57 Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Diff. 2002; 9: 6-19

58 Distelhorst W, Dubyak G. Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings. Blood. 1998; 91: 731-4


[Seite 108↓]

59 Eagle H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc Soc Exp Biol Med. 1955; 89(3): 362-4

60 Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem. 1991; 266(11): 7182-8

61 Evans SJ, Moore FL, Murray TF. Solubilization and pharmacological characterization of a glucocorticoid membrane receptor from an amphibian brain. J Steroid Biochem. 1998; 67(1): 1-8

62 Falkenstein E, Tillmann HC, Christ M, Feurig M, Wehling M. Multiple actions of steroid hormones – a focus on rapid nongenomic effects. Pharmacol Rev. 2000; 52(4): 513-56

64 Falkenstein E, Meyer C, Eisen C, Scriba PC, Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun. 1996; 229(1): 86-9

64 Ferrari P. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. Best Pract Res Clin Endocrinol Metab. 2003; 17(4): 575-89

65 Gametchu B, Watson CS. Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines. J Cell Biochem. 2002; 87(2): 133-46

66 Gametchu B, Chen F, Sackey F, Powell C, Watson CS. Plasma membrane resident glucocorticoid receptors in rodent lymphoma and human leucemia models. Steroids. 1999; 64: 107-19

67 Gametchu B, Watson CS, WU S. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leucemic patients. FASEB. 1993; 7(13): 1283-92

68 Gametchu B. Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science. 1987; 236(4800): 456-61

69 Gametchu B, Harrison RW. Characterization of a monoclonal antibody to the rat liver glucocorticoid receptor. Endocrinology. 1984; 114(1): 274-9

70 Giacomelli R, Cipriani P, Danese C, Pizzuto F, Lattanzio R, Parzanese I, Passacantando A, Perego MA, Tonietti G. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. J Rheumatol. 1996; 23(2): 291-6

71 Gold R, Buttgereit F, Toyka KV. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol. 2001; 117(1-2): 1-8

72 Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol. 1993; 5(1): 108-13

73 Greiner EF, Guppy M, Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem. 1994; 269(50): 31484-90

74 Griffiths CE. Keeping psoriasis under wraps. J Dermatolog Treat. 2001; 12(3): 133


[Seite 109↓]

75 Groner B, Hynes NE, Rahmsdorf U, Ponta H. Transcription initiation of transfected mouse mammary tumor virus LTR DNA is regulated by glucocorticoid hormones. Nucleic Acids Res. 1983; 11(14): 4713-25

76 Grove A, Allam C, McFarlane LC, McPhate G, Jackson CM, Lipworth BJ. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol. 1994; 38(6): 527-32

77 Guppy M, Greiner E, Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem. 1993; 212(1): 95-9

78 Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Holtje HD, Korting HC. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.Pharm Res. 1999. 16(9); 1386-91

79 Hall ED. Pharmacological treatment of acute spinal cord injury: how do we build on past success. J Spinal Cord Med. 2001; 24(3): 142-6

80 Hall ED, McCall JM, Means ED. Therapeutic potential of lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Advanc Pharmacol. 1994; 28: 221-68

81 Hammer S, Spika I, Sippl W, Jessen G, Kleuser B, Höltje HD, Schäfer-Korting M. Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants. Steroids. 2003; 68: 329-39

82 Hatz HJ. Glucocorticoide - immunologische Grundlagen, Pharmakologie und Therapierichtlinien. Hatz HJ. Stuttgart, Wissenschaftliche Verlagsgesellschaft mbh, 1998

83 Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 1995; 14(3): 452-60

84 Hench PS, Kendall PD, Slocumb CH, Polley HF. The efect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Pro Staff Meet Mayo Clin. 1949; 24: 183

85 Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene. 2001; 20(19): 2465-75

86 Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990; 11(12): 443-9

87 Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985; 318(6047): 635-41

88 Hofmann TG, Hehner SP, Bacher S, Droge W, Schmitz ML. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription. FEBS Lett. 1998; 441(3): 441-6


[Seite 110↓]

89 Hulkko SM, Wakui H, Zilliacus J. The pro-apoptotic protein death-associated protein 3 (DAP3) interacts with the glucocorticoid receptor and affects the receptor function. Biochem J. 2000; 349 Pt 3: 885-93

90 Hummel M, Czerlinski S, Friedel N, Liebenthal C, Hasper D, von Baehr R, Hetzer R, Volk HD. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Crit Care Med. 1994; 22(3): 448-54

91 Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000; 20(18): 6891-903

92 Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 1993; 268(15): 10932-7

93 Janeway CA, Travers P. Immunology. Second edition, Heidelberg-Berlin-Oxford, Spektrum Akademischer Verlag, 1997, 56-64

94 Kaiser H, Klingenberg N. Cortison – die Geschichte eines Medikaments. Darmstadt, Wiss. Buchges., 1988,

95 Kaiser H. Hochdosierte Corticoidtherapie. Int. Praxis. 1991; 151

96 Kaiser H, Kley HK. Cortisontherapie. 10. Auflage, Stuttgart-New York, Georg Thieme Verlag, 1997,

97 Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?. Cell. 1998; 93(4): 487-90

98 Karlsson H, De Pierre JW, Nassberger L. Energy levels in resting and mitogen-stimulated human lymphocytes during treatment with FK506 or cyclosporine in vitro. Biochim Biophys Acta. 1997; 1319: 301-10

99 Kemeny DM, Challacombe SJ. Microtiter plates and other solid-phase supports. ELISA and other solid-phase immunoassays. Theoretical and practical aspects. Chichester, UK, John Wiley and sons ltd, 1994

100 King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol. 1998; 60: 601-17

101 Kirwan JR. Systemic low-dose glucocorticoid treatment in rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27(2): 389-403

102 Klippel JH. Systemic lupus erythematodes. Management. Hrsg.: Klippel JH, Dieppe PH: Rheumatology. 2nd edition, London, Mosby, 1998, 1-8

103 Koukouritaki SB, Margioris AN, Gravanis A, Hartig R, Stournaras C. Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis. J Cell Biochem. 1997; 65(4): 492-500

104 Krauss S, Buttgereit F, Brand MD. Effects of the mitogen concanavalin A on pathways of thymocyte energy metabolism. Biochim Biophys Acta. 1999; 1412(2): 129-38

105 Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 1997; 18(1): 44-51


[Seite 111↓]

106 Kuhnke A, Burmester GR, Krauss S, Buttgereit F. Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocortioid treatment. Ann Rheum Dis. 2003; 62: 133-9

107 Lamche HR, Silberstein PT, Knabe AC, Thomas DD, Jacob HS, Hammerschmidt DE. Steroids decrease granulocyte membrane fluidity, while phobol ester increases membrane fluidity. Inflammation. 1990; 14: 61-70

1ß8 Langford CA. Management of systemic vasculitis. Best Pract Res Clin Rheumatol. 2001; 15: 281-97

109 Leist M. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997; 185: 1481-6

110 Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol. 2001; 58(1): 91-7

111 Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002; 67(6): 471-5

112 Levine SJ, Benfield T, Shelhamer JH. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol. 1996; 15(2): 245-51

113 Li C, Dasgupta B. Corticosteroids in polymyalgia rheumatica. A review of different treatment schedules. Clin Exp Rheum. 2000; 18(Suppl 20): 56-7

114 Liddell E, Weeks I. Antikörpertechniken. Heidelberg, Berlin, Oxford, Spektrum Akademischer Verlag, 1995

115 Lipworth BJ. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther. 1993; 58: 173-209

116 Lösel R, Wehling M. Nongenomic actions of steroid hormones. Nature Mol Cell Biol. 2003; 4: 46-56

117 Lozewicz S, Wang J, Duddle J, Thomas K, Chalstrey S, Reilly G. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol. 1992; 89: 951-7

118 Luconi M, Bonaccorsi L, Bini L, Liberatori S, Pallini V, Forti G. Characterization of membrane nongenomic receptors for progesteron in human spermatozoa. Steroids. 2002; 67(6): 505-9

119 Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood. 2003; 101(2): 585-93

120 Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996; 184(3): 1155-60

121 Masera RG, Dovio A, Sartori ML, Racca S, Angeli A. Interleukin-6 upregulates glucocorticoid receptor numbers in human osteoblast-like cells. Z Rheumatol. 2000; 59(2): 102-7


[Seite 112↓]

122 Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB. Topical glucocorticoid inhibits cell expressing mRNA for interleukin 4 in the nasal mucosa in allergen induced rhinitis. Immunology. 1994; 82: 192-9

123 Meinig G, Deisenroth K. Dose-response relation for dexamethasone in cold lesion-induced brain edema in rats. Adv Neurol. 1990; 52: 295-300

124 Migita K, Eguchi K, Kawabe Y, Nakamura T, Shirabe S, Tsukada T, Ichinose Y, Nakamura H, Nagataki S. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation. 1997; 63(4): 583-7

125 Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachi A, Yonehara S, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol. 1992; 149: 3753-8

126 Morand EF. Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol. 2000; 12(3): 171-7

127 Muller M, Siems W, Buttgereit F, Dumdey R, Rapoport SM. Quantification of ATP-producing and consuming processes of Ehrlich ascites tumour cells.Eur J Biochem. 1986; 161(3): 701-5.

128 Munck A, Brinck-Johnsen T. Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J Biol Chem. 1968; 243(21): 5556-65

129 Mursch K, Buhre W, Behnke-Mursch J, Markakis E. Peroperative cardiovascular stability during brainstem surgery. The use of high-dose methylprednisolone compared to dexamethasone. A retrospective analysis. Acta Anaesthesiol Scand. 2000; 44(4): 378-82

130 Mygind N, Lund V. Topical corticosteroid therapy of rhinitis. Clin Immunother. 1996; 5: 122-36

131 Navarrete MG, Brey RL. Neuropsychiatric Systemic Lupus Erythematosus. Curr Treat Options Neurol. 2000; 2(5): 473-485

132 Nissen RM, Yamamoto KR. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 2000; 14(18): 2314-29

133 Norman AW, Olivera CJ, Barreto Silva FR, Bishop JE. A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Biochem Biophys Res Commun. 2002; 298(3): 414-9

134 Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor ß isoform. J Biol Chem. 1999; 274(39): 27857-66

135 Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993; 81(11): 2844-53

136 Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science. 1991; 252(5014): 1848-51

137 Orchinik M, Murray TF, Franklin PH, Moore FL. Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci. 1992; 89(9): 3830-4

138 Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone. 2001; 29(6): 498-505


[Seite 113↓]

139 Peters M, Müller AM, Rose-John S. Interleukin-6 and soluble Interleukin-6 receptor: direct stimulation of gp 130 and hematopoiesis. Blood. 1998; 92(10): 3495-504

140 Pfister R, Menz G. Glucocorticosteroid therapy in bronchial asthma. Pneumologie. 1995; 49(5): 293-305

141 Planey SL, Litwack G. Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun. 2000; 279(2): 307-12

142 Ponec M, Kempenaar J, Shroot B, Caron JC. Glucocorticoids: binding affinity and lipophilicity. J Pharm Sci. 1986; 75(10): 973-5

143 Pörtner M, Möllmann H, Rohdewald P. Glucocorticoid receptors in human synovial tissue and relative receptor affinities of glucocorticoid-21-esters. Pharm Res. 1988; 5: 623-7

144 Pratt WB. The hsp90 based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med. 1998; 217(4): 420-34

145 Qiu J, Lou LG, Huang XY, Lou SJ, Pei G, Chen YZ. Nongenomic mechanisms of glucocorticoid inhibition of nicotine-induced calcium-influx in PC12 cells: involvement of proteinkinase C. Endocrinology. 1998; 139(12): 5103-8

146 Qiu J, Wang P, Jing Q, Zhang W, Li X, Zhong Y, Sun G, Pei G, Chen YZ. Rapid activation of ERK1/2 mitogen activated proteinkinase by corticosterone in PC12 cells. Biochem Biophys Res Commun. 2001; 29(4): 1017-24

147 Rapoport SM, Raderecht HJ. Physiologisch-chemisches Praktikum. 7. Aufl., VEB Verlag Volk und Gesundheit Berlin, 1977, 156-9

148 Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol. 1999; 13(2): 307-19

149 Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P, Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 2001; 20(24): 7168-73

150 Reichardt HM, Tuckermann JP, Bauer A, Schutz G. Molecular genetic dissection of glucocorticoid receptor function in vivo. Z Rheumatol. 2000; 59 Suppl 2: 1-5

151 Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998; 93(4): 531-41

152 Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997; 77(3): 731-58

153 Rupprecht R, Reul JM, van Steensel B, Spengler D, Soder M, Berning B, Holsboer F, Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993; 247(2): 145-54


[Seite 114↓]

154 Sachs L. Angewandte Statistik. 7. Aufl., Berlin-Heidelberg-New York, Springer Verlag, 1992,

155 Sackey FN, Watson CS, Gametchu B. Cell cycle regulation of membrane glucocorticoid receptor in CCRF-CEM human ALL cells: correlation to apoptosis. Am J Physiol. 1997; 273(3 Pt 1): E571-83

156 Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1): 55-89

157 Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 1992; 35(7): 740-4

158 Schmid BM, Gerdes D, Feuring M, Falkenstein E, Christ M, Wehling M. Rapid nongenomic steroid actions: A new age?. Front Neuroendocrinol. 2000; 21(1): 57-94

159 Schmid D, Burmester GR, Tripmacher R, Kuhnke A, Buttgereit F. Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated and glucocorticoid-treated states. Biosci Rep. 2000; 20: 289-302

160 Schmidt J, Gold R, Schonrock L, Zettl UK, Hartung HP, Toyka KV. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain. 2000; 123( Pt 7): 1431-41

161 Schulz M, Zhang R, Eggert H, Boeke J, Neeck G, Eggert M, Renkawitz R. Distinct proteins interacting with the glucocorticoid receptor. Z Rheumatol. 2000; 59(Suppl 2): 6-11

162 Seeto C, Namkung-Matthai H, Jayram S, Foe K, Brown KF, Hughes JM, Mason RS, Armour CL, Seale JP. Differential potency of beclomethasone esters in-vitro on human T-lymphocyte cytokine production and osteoblast activity. J Pharm Pharmacol. 2000; 52: 417-23

163 Seshagiri PB, Bavister BD. Glucose and phosphate inhibit respiration and oxidative metabolism in cultured hamster eight-cell embryos: evidence for the "crabtree effect". Mol Reprod Dev. 1991; 30(2): 105-11

164 Shroot B, Caron JC, Ponec M. Glucocorticoid specific binding: structure-activity relationships. Br J Dermatol. 1982; 107 Suppl 23: 30-4

165 Simon N, Jolliet P, Morin C, Zini R, Urien S, Tillement JP. Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria. FEBS Lett. 1998; 435(1): 25-8

166 Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology. 2003; 144(4): 1164-74

167 Steinmetz HT, Herbertz A, Bertram M, Diehl V. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis. J Infect Dis. 1995; 171(1): 225-8


[Seite 115↓]

168 Sudlow AW, Carey F, Forder R, Rothwell NJ. The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells. Br J Pharmacol. 1996; 117(7): 1449-56

169 Suter D, Weidemann MJ. Regulation of carbohydrate metabolism in lymphoid tissue. Nature of the endogenous substrates and their contribution to the respiratory fuel of the sliced rat spleen in vitro. Biochem J. 1976; 156(1): 119-27

170 Trampisch HJ, Windeler J, Ehle B, Lange S. Medizinische Statistik. Berlin-Heidelberg-New York, Springer Verlag, 1997

171 Tyrrell JB. Glucocorticoid therapy. Hrsg.: Felig P, Baxter JD, Frohman LA: Endocrinology and metabolism. 3rd edition, New York, McGraw-Hill, Inc., 1995, 855-82

172 Umland SP, Schleimer RP, Johnston SL. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther. 2002; 15(1): 35-50

173 Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M, Haegeman G. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Mol Pharmacol. 1999; 56(4): 797-806

174 Volpin R, Angeli P, Galioto A, Fasolato S, Neri D, Barbazza F, Merenda R, Del Piccolo F, Strazzabosco M, Casagrande F, Feltracco P, Sticca A, Merkel C, Gerunda G, Gatta A. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl. 2002; 8(6): 527-34

175 Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Ann Rev Immunol. 2002; 20: 125-63

176 Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol. 1997; 59: 365-93

177 Westgard JO. A multi-rule chart for quality control. Clin Chem. 1981; 27: 493-501

178 Whelan CJ, Payne AN, Planquois JM. A comparison of the inhibitory effects of budesonide, beclomethasone dipropionate, dexamethasone, hydrocortisone and tixocortol pivalate on cytokine release from leukocytes recovered from human bronchoalveolar lavage. Inflamm Res. 1999; 48: 224-8

179 Wolff ME, Baxter JD, Kollman PA, Kuntz ID, Bloom E, Matulich DT, Morris J. Nature of steroid-glucocorticoid receptor interactions: thermodynamic analysis of the binding reaction. Biochemistry. 1978; 17: 3201-8

180 Wunderlich F, Benten WP, Lieberherr M, Guo Z, Stamm O, Wehlke C, Sekeris CE, Mossmann H. Testosterone signalling in T cells and macrophages. Steroids. 2002; 67(6): 535-8

181 Würthwein G, Rohdewald P. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate. Biopharm Drug Dispos. 1990; 11: 381-94


[Seite 116↓]

182 Yang Y, Mercep M, Ware CF, Ashwell JD. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med. 1995; 181: 1673-82

183 Yonehara S. Effects of anti-Fas antibodies on lymphocytes and other organs: preparation of original and new monoclonal antibodies and amelioration of systemic autoimmune disease. Int Rev Immunol. 1999; 18(4): 329-45

184 Yonehara S, Nishimura Y, Kishil S. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol. 1994; 1849-56

185 Yoshino T, KondoE, Cao L, Takahashi K, Hayashi K, Nomura S, Agaki T. Inverse expression of bcl-2 and Fas antigen in lymphoblasts in peripheral lymphnodes and activated peripheral blood T and B lymphocytes. Blood. 1994; 83: 1856-61

186 Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, Ahern MJ, Smith MD. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum. 1997; 40(8): 1400-8

187 Yudt MR, Cidlowski JA. The glucocorticoid receptor: coding for a diversity of proteins and responses through a single gene. Mol Endocrinol. 2002; 16(8): 1719-26

188 Yudt MR, Cidlowski JA. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol Endocrinol. 2001; 15(7): 1093-103

189 Zhang X, Moilanen E, Kankaanranta H. Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Eur J Pharmacol. 2000; 406: 325-32

190 Zempleni J, Mock DM. Mitogen-induced proliferation increases biotin uptake into human peripheral blood mononuclear cells. Am J Physiol. 1999; 276(5 Pt 1): C1079-84


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
26.04.2005